CDK inhibitor p57Kip2 is negatively regulated by COP9 signalosome subunit 6

Cell Cycle

Volumn 11, Issue 24, 2012, Pages 4633-4641

  Chen, Bo ^a,c   Zhao, Ruiying ^a,b   Su, Chun Hui ^a   Linan, Monica ^a   Tseng, Chieh ^a   Phan, Liem ^a   Fang, Lekuan ^a   Yang, Heng Yin ^a   Yang, Huiling ^a   Wang, Wenqian ^c   Xu, Xiaoyin ^c   Jiang, Nan ^c   Cai, Shouliang ^c   Jin, Feng ^c   Yeung, Sai Ching J ^a   Lee, Mong Hong ^a,b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Cell cycle; COP9; CSN6; p57; Skp2

Indexed keywords

COP9 SIGNALOSOME; CSN6 PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1C; S PHASE KINASE ASSOCIATED PROTEIN 2; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANCER GROWTH; CELL CYCLE REGULATION; CELL GROWTH; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; OVERALL SURVIVAL; PROTEIN DEGRADATION; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN STABILITY; PROTEIN TARGETING; REGULATORY MECHANISM; STEADY STATE; UBIQUITINATION;

EID: 84871512500     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.22887     Document Type: Article

References (37)

1. Tomoda K, Kubota Y, Kato J. Degradation of the cyclin-dependent-kinase inhibitor p27Kip1 is instigated by Jab1. Nature 1999; 398:160-5; PMID:10086358; http://dx.doi.org/10.1038/18230.
2. Naumann M, Bech-Otschir D, Huang X, Ferrell K, Dubiel W. COP9 signalosome-directed c-Jun activation/stabilization is independent of JNK. J Biol Chem 1999; 274:35297-300; PMID:10585392; http://dx.doi.org/10.1074/jbc.274. 50.35297.
3. Bech-Otschir D, Kraft R, Huang X, Henklein P, Kapelari B, Pollmann C, et al. COP9 signalosome-specific phosphorylation targets p53 to degradation by the ubiquitin system. EMBO J 2001; 20:1630-9; PMID:11285227; http://dx.doi.org/10. 1093/emboj/20.7.1630.
4. Zhao R, Yeung SC, Chen J, Iwakuma T, Su CH, Chen B, et al. Subunit 6 of the COP9 signalosome promotes tumorigenesis in mice through stabilization of MDM2 and is upregulated in human cancers. J Clin Invest 2011; 121:851-65; PMID:21317535; http://dx.doi.org/10.1172/JCI44111.
5. Zhang XC, Chen J, Su CH, Yang HY, Lee MH. Roles for CSN5 in control of p53/MDM2 activities. J Cell Biochem 2008; 103:1219-30; PMID:17879958; http://dx.doi.org/10.1002/jcb.21504.
6. Choi HH, Gully C, Su CH, Velazquez-Torres G, Chou PC, Tseng C, et al. COP9 signalosome subunit 6 stabilizes COP1, which functions as an E3 ubiquitin ligase for 14-3-3σ. Oncogene 2011; 30:4791-801; PMID:21625211; http://dx.doi.org/10.1038/onc.2011.192.
7. Wei N, Deng XW. The COP9 signalosome. Annu Rev Cell Dev Biol 2003; 19:261-86; PMID:14570571; http://dx.doi.org/10.1146/annurev.cell-bio.19.111301. 112449.
8. Lee MH, Zhao R, Phan L, Yeung SC. Roles of COP9 signalosome in cancer. Cell Cycle 2011; 10:3057-66; PMID:21876386; http://dx.doi.org/10.4161/cc.10.18. 17320.
9. Karniol B, Chamovitz DA. The COP9 signalosome: from light signaling to general developmental regulation and back. Curr Opin Plant Biol 2000; 3:387-93; PMID:11019806; http://dx.doi.org/10.1016/S1369-5266(00)00101-1.
10. Li L, Deng XW. The COP9 signalosome: an alternative lid for the 26S proteasome? Trends Cell Biol 2003; 13:507-9; PMID:14507477; http://dx.doi.org/ 10.1016/j.tcb.2003.08.002.
11. Polyak K, Lee MH, Erdjument-Bromage H, Koff A, Roberts JM, Tempst P, et al. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 1994; 78:59-66; PMID:8033212; http://dx.doi.org/10.1016/0092-8674(94)90572-X.
12. Lee MH, Reynisdóttir I, Massagué J. Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev 1995; 9:639-49; PMID:7729683; http://dx.doi.org/10.1101/ gad.9.6.639.
13. Lee MH, Yang HY. Negative regulators of cyclin-dependent kinases and their roles in cancers. Cell Mol Life Sci 2001; 58:1907-22; PMID:11766887; http://dx.doi.org/10.1007/PL00000826.
14. Yan Y, Frisén J, Lee MH, Massagué J, Barbacid M. Ablation of the CDK inhibitor p57Kip2 results in increased apoptosis and delayed differentiation during mouse development. Genes Dev 1997; 11:973-83; PMID:9136926; http://dx.doi.org/10.1101/gad.11.8.973.
15. Zhang P, Liégeois NJ, Wong C, Finegold M, Hou H, Thompson JC, et al. Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in Beckwith-Wiedemann syndrome. Nature 1997; 387:151-8; PMID:9144284; http://dx.doi.org/10.1038/387151a0.
16. Lee MH, Yang HY. Regulators of G1 cyclin-dependent kinases and cancers. Cancer Metastasis Rev 2003; 22:435-49; PMID:12884917; http://dx.doi.org/10.1023/ A:1023785332315.
17. Kavanagh E, Joseph B. The hallmarks of CDKN1C (p57, KIP2) in cancer. Biochim Biophys Acta 2011; 1816:50-6; PMID:21447370.
18. Guo H, Tian T, Nan KJ, Wang W. p57: A multifunctional protein in cancer (Review). [Review]. Int J Oncol 2010; 36:1321-9; PMID:20428755.
19. Borriello A, Caldarelli I, Bencivenga D, Criscuolo M, Cucciolla V, Tramontano A, et al. p57(Kip2) and cancer: time for a critical appraisal. Mol Cancer Res 2011; 9:1269-84; PMID:21816904; http://dx.doi.org/10.1158/1541-7786. MCR-11-0220.
20. Kamura T, Hara T, Kotoshiba S, Yada M, Ishida N, Imaki H, et al. Degradation of p57Kip2 mediated by SCFSkp2-dependent ubiquitylation. Proc Natl Acad Sci USA 2003; 100:10231-6; PMID:12925736; http://dx.doi.org/10.1073/pnas. 1831009100.
21. Zhou BP, Liao Y, Xia W, Zou Y, Spohn B, Hung MC. HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation. Nat Cell Biol 2001; 3:973-82; PMID:11715018; http://dx.doi.org/10.1038/ncb1101-973.
22. Xue Y, Chen J, Choi HH, Phan L, Chou PC, Zhao R, et al. HER2-Akt signaling in regulating COP9 signalsome subunit 6 and p53. Cell Cycle 2012; 11:4181-90; PMID:23095642; http://dx.doi.org/10.4161/cc.22413.
23. Jin J, Ang XL, Shirogane T, Wade Harper J. Identification of substrates for F-box proteins. Methods Enzymol 2005; 399:287-309; PMID:16338364; http://dx.doi.org/10.1016/S0076-6879(05)99020-4.
24. Rinaldi T, Bolotin-Fukuhara M, Frontali L. A Saccharomyces cerevisiae gene essential for viability has been conserved in evolution. Gene 1995; 160:135-6; PMID:7628709; http://dx.doi.org/10.1016/0378-1119(95)00212-O.
25. Penney M, Wilkinson C, Wallace M, Javerzat JP, Ferrell K, Seeger M, et al. The Pad1+ gene encodes a subunit of the 26 S proteasome in fission yeast. J Biol Chem 1998; 273:23938-45; PMID:9727008; http://dx.doi.org/10.1074/jbc.273. 37.23938.
26. Wei N, Deng XW. Making sense of the COP9 signalosome. A regulatory protein complex conserved from Arabidopsis to human. Trends Genet 1999; 15:98-103; PMID:10203806; http://dx.doi.org/10.1016/S0168-9525(98)01670-9.
27. Maytal-Kivity V, Reis N, Hofmann K, Glickman MH. MPN+, a putative catalytic motif found in a subset of MPN domain proteins from eukaryotes and prokaryotes, is critical for Rpn11 function. BMC Biochem 2002; 3:28; PMID:12370088; http://dx.doi.org/10.1186/1471-2091-3-28.
28. Lyapina S, Cope G, Shevchenko A, Serino G, Tsuge T, Zhou C, et al. Promotion of NEDD-CUL1 conjugate cleavage by COP9 signalosome. Science 2001; 292:1382-5; PMID:11337588; http://dx.doi.org/10.1126/science.1059780.
29. Kim M, Nakamoto T, Nishimori S, Tanaka K, Chiba T. A new ubiquitin ligase involved in p57KIP2 proteolysis regulates osteoblast cell differentiation. EMBO Rep 2008; 9:878-84; PMID:18660753; http://dx.doi.org/10.1038/embor.2008.125.
30. Arboleda VA, Lee H, Parnaik R, Fleming A, Banerjee A, Ferraz-de-Souza B, et al. Mutations in the PCNA-binding domain of CDKN1C cause IMAGe syndrome. Nat Genet 2012; 44:788-92; PMID:22634751; http://dx.doi.org/10.1038/ng.2275.
31. Riccio A, Cubellis MV. Gain of function in CDKN1C. Nat Genet 2012; 44:737-8; PMID:22735584; http://dx.doi.org/10.1038/ng.2336.
32. Iyer SV, Iwakuma T. A novel link between the HER2-Akt and MDM2-p53 pathways via CSN6. Cell Cycle 2012; 11:4112; PMID:23099920; http://dx.doi.org/ 10.4161/cc.22606.
33. Yang H, Zhao R, Yang HY, Lee MH. Constitutively active FOXO4 inhibits Akt activity, regulates p27 Kip1 stability, and suppresses HER2-mediated tumorigenicity. Oncogene 2005; 24:1924-35; PMID:15688030; http://dx.doi.org/10. 1038/sj.onc.1208352.
34. Reynisdóttir I, Polyak K, Iavarone A, Massagué J. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta. Genes Dev 1995; 9:1831-45; PMID:7649471; http://dx.doi.org/10.1101/ gad.9.15.1831.
35. Bashir T, Dorrello NV, Amador V, Guardavaccaro D, Pagano M. Control of the SCF(Skp2-Cks1) ubiquitin ligase by the APC/C(Cdh1) ubiquitin ligase. Nature 2004; 428:190-3; PMID:15014502; http://dx.doi.org/10.1038/nature02330.
36. Laronga C, Yang HY, Neal C, Lee MH. Association of the cyclin-dependent kinases and 14-3-3 sigma negatively regulates cell cycle progression. J Biol Chem 2000; 275:23106-12; PMID:10767298; http://dx.doi.org/10.1074/jbc. M905616199.
37. Yang HY, Shao R, Hung MC, Lee MH. p27 Kip1 inhibits HER2/neu-mediated cell growth and tumorigenesis. Oncogene 2001; 20:3695-702; PMID:11439332; http://dx.doi.org/10.1038/sj.onc.1204472.